FDA Inspection 1177989 — Department Of Defense-Navy; US Naval Hospital Yokosuka

Department Of Defense-Navy; US Naval Hospital Yokosuka — FEI 3002809468

The FDA completed an inspection of Department Of Defense-Navy; US Naval Hospital Yokosuka on Jul 19, 2022 in Yokosuka. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jul 19, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Yokosuka (Japan)